We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03888105
Brief Title: Assess the Anti-Tumor Activity and Safety of Odronextamab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (ELM-2)

First Submitted : March 14, 2019
First Submitted that Met QC Criteria : March 20, 2019
First Posted : March 25, 2019

Last Update Submitted that Met QC Criteria : January 4, 2023
Last Update Posted : January 5, 2023